Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Penile Neoplasms 1 Non-Small Cell Lung Cancer With HER2- Mutations 1 Melanoma 1 Male Urogenital Diseases 1 Lung Neoplasms 1 First-line Advanced NSCLC Patients 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasms 1

Interventions

pembrolizumab 49 Carboplatin 44 Magnetic Resonance Spectroscopy 40 Specimen Handling 39 Pemetrexed 34 Cisplatin 25 Blood Specimen Collection 25 durvalumab 17 Paclitaxel 16 osimertinib 15 Radiotherapy 15 Radiosurgery 15 Bevacizumab 15 Gemcitabine 14 atezolizumab 13 Nivolumab 13 Biopsy 13 Drug Therapy 12 Standard of Care 10 Practice Guidelines as Topic 10 Immunoglobulin G 10 Docetaxel 10 130-nm albumin-bound paclitaxel 10 X-Rays 9 Taxes 9 Educational Status 9 Disulfides 9 tislelizumab 8 Etoposide 8 Cetuximab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Neoplasms × CP protocol × Clear all

NCT05061550 2026-05-22

NeoCOAST-2

AstraZeneca

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡